Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Why Is This Training Provided?<br />OSHA mandates<br />   training on OSHA<br />   regulations for ALL<br />workers at the...
Bloodborne Pathogens: Transmission in Healthcare Settings<br />Occupationalexposures that <br />     may result in HIV, HB...
Hepatitis B Vaccination: Methods of Compliance<br />Hepatitis B vaccination shall be <br />    made available after the <b...
Guidelines for Preventing the Transmissionof Mycobacterium tuberculosisin Health-Care Settings:<br />TB Infection-Control ...
QuantiFERON-TB Gold:<br />What are the advantages?<br />The QuantiFERON®-TB Gold <br />     test (QFT-G) is a whole-<br />...
Upcoming SlideShare
Loading in …5
×

Bloodborne Pathogens Training - OSHA Plus

1,381 views

Published on

OSHA Plus™ is designed for healthcare facilities seeking comprehensive OSHA Healthcare compliance training. Its universal application is suitable for the largest hospital chains all the way down to the smallest private practices. OSHA Plus™ includes 5 distinct training modules including: bloodborne pathogens, personal protective equipment, hazard communication, tuberculosis infection control and emergency action & fire safety plan standards. This program is widely accepted in the medical community and has been adopted by virtually every healthcare segment as their standardized platform for delivering OSHA healthcare compliance training.

OSHA Optics, LLC
www.OSHAOptics.com
Compliance@OSHAOptics.com

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Bloodborne Pathogens Training - OSHA Plus

  1. 1. Why Is This Training Provided?<br />OSHA mandates<br /> training on OSHA<br /> regulations for ALL<br />workers at the time <br /> of initial assignment <br /> to tasks where <br /> occupational <br /> exposure may take <br /> place and at least <br /> annually thereafter.<br />Subjects Covered In This Training Program<br />
  2. 2. Bloodborne Pathogens: Transmission in Healthcare Settings<br />Occupationalexposures that <br /> may result in HIV, HBV, or <br /> HCV transmission include<br />needlestick and other sharps <br /> injuries; direct inoculation of <br /> virusinto cutaneous <br /> scratches, skin lesions, <br /> abrasions, or burns; <br /> andinoculation of virus onto <br /> mucosal surfaces of the <br /> eyes, nose,or mouth through <br /> accidental splashes.<br />In the healthcare <br /> setting, bloodborne <br /> pathogen transmission <br /> occurs predominantly by <br /> percutaneous or mucosal <br /> exposure ofworkers to the <br /> blood or body fluids of <br /> infected patients.<br />NOTE:HIV, HBV, and HCV do not<br />spontaneously penetrate intact <br /> skin, and airborne transmissionof <br /> these viruses does notoccur.<br />
  3. 3. Hepatitis B Vaccination: Methods of Compliance<br />Hepatitis B vaccination shall be <br /> made available after the <br /> employee has received<br /> training on the hepatitis B <br /> vaccine and within 10 working <br /> days of initial assignment to<br /> all employees who have <br /> occupational exposure unless<br /> the employee has previously <br /> received the complete<br /> hepatitis B vaccination series, <br /> antibody testing has revealed<br /> that the employee is immune,<br /> or the vaccine is<br /> contraindicated for medical <br /> reasons.<br />If the employee initially declines<br /> hepatitis B vaccination but at a later <br /> date while still covered under the <br /> standard decides to accept the <br /> vaccination, the employer shall make <br /> available the hepatitis B vaccination <br /> at that time.<br />The employer shall assure that <br /> employees who decline to accept <br /> hepatitis B vaccination offered by the <br /> employer sign a mandatory Hepatitis <br /> B Vaccine Declination Form.<br />
  4. 4. Guidelines for Preventing the Transmissionof Mycobacterium tuberculosisin Health-Care Settings:<br />TB Infection-Control Program for Settings in Which Patients with Suspected<br />or Confirmed TB Disease Are Expected To Be Encountered:<br /><ul><li>Assign supervisory responsibility </li></ul> for the TB infection-control <br /> program<br /><ul><li>Collaborate with the local or state </li></ul> health department to develop <br /> administrative controls<br /><ul><li>Develop a written TB infection-</li></ul> control plan <br /><ul><li>Implement and maintain </li></ul> environmental controls<br /><ul><li>Conduct a problem evaluation if a </li></ul> case of suspected or confirmed TB <br /> disease is not promptly recognized <br /> and appropriate airborne <br /> precautions not initiated, or if <br /> administrative, environmental, or <br /> respiratory-protection controls fail <br /><ul><li>Implement a respiratory- </li></ul> protection program<br /><ul><li>Perform ongoing training and </li></ul> education for Healthcare Workers<br /><ul><li>Create a plan for accepting patients </li></ul> who have suspected or confirmed <br /> TB disease if they are transferred <br /> from another setting<br /><ul><li>Perform a contact investigation in </li></ul> collaboration with the local or state <br /> health department<br />Source: MMWR, December 30, 2005<br />
  5. 5. QuantiFERON-TB Gold:<br />What are the advantages?<br />The QuantiFERON®-TB Gold <br /> test (QFT-G) is a whole-<br /> blood test for use as an aid <br /> in diagnosing <br /> Mycobacterium tuberculosis <br /> infection, including latent <br /> tuberculosis infection (LTBI) <br /> and tuberculosis (TB) <br /> disease. This test was <br /> approved by the U.S. Food <br /> and Drug Administration <br /> (FDA) in 2005. <br /><ul><li>Requires a single patient visit to </li></ul> draw a blood sample. <br /><ul><li>Results can be available within 24 </li></ul> hours. <br /><ul><li>Does not boost responses measured </li></ul> by subsequent tests, which can <br /> happen with tuberculin skin tests <br /> (TST). <br /><ul><li>Is not subject to reader bias that can </li></ul> occur with TST. <br /><ul><li>Is not affected by prior BCG (bacille </li></ul> Calmette-Guérin) vaccination. <br />Source: Division of Tuberculosis Elimination, CDC, 11/16/07<br />

×